Circulating immune complexes in colon cancer patient sera
β Scribed by Sandra S. Ristow; Roger D. Rossen; David S. Fryd; Charles F. McKhann
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 686 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Sera from 62 patients with osteogenic sarcoma and 12 with malignant giantβcell tumour were tested for the presence of immune complexes by the ^125^IβClq binding assay. Elevated serum Clq binding activity was found in 67.7% of the osteogenic sarcoma patients and in 75% of the giantβcell
An assay which could prospectively predict a response to chemotherapy prior to instituting therapy would be beneficial, especially for nonresponders. We evaluated at random a total of 50 patients with previously untreated stage 111 and IV head and neck squamous cell carcinoma for T-cell subsets and
To examine autoantibodies present in patients with active systemic lupus erythematosus (SLE), sera, circulating immune comptexes (CIC), and antibodies purified on DNA-immunoadsorbent were tested by enzyme immunoassay. A panel of self-antigens, including DNA, histones (HIS), glomerular basal membrane